111In-DTPA-Biotin uptake by Staphylococcus aureus

Nuclear Medicine Communications

Volumn 31, Issue 11, 2010, Pages 994-997

  Erba, Paola Anna ^a   Cataldi, Angela G ^a   Tascini, Carlo ^b   Leonildi, Alessandro ^b   Manfredi, Chiara ^a   Mariani, Giuliano ^a   Lazzeri, Elena ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

111In DTPA Biotin; growth factor; Staphylococcus aureus

Indexed keywords

BIOCYTIN; DIETHYLENETRIAMINEPENTAACETIC ACID ALPHA,OMEGA BIS(BIOCYTINAMIDE) INDIUM 111; TRACER; UNCLASSIFIED DRUG; BIOTIN; DIAGNOSTIC AGENT; INDIUM; PENTETIC ACID;

ARTICLE; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG STABILITY; DRUG SYNTHESIS; DRUG UPTAKE; IN VITRO STUDY; INCUBATION TIME; ISOTOPE LABELING; NONHUMAN; STAPHYLOCOCCUS AUREUS; AEROBIC METABOLISM; CHEMISTRY; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; SPINE; STAPHYLOCOCCUS INFECTION; TIME; TRANSPORT AT THE CELLULAR LEVEL;

AEROBIOSIS; BIOLOGICAL TRANSPORT; BIOTIN; DRUG STABILITY; INDIUM RADIOISOTOPES; PENTETIC ACID; REPRODUCIBILITY OF RESULTS; SPINE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TIME FACTORS;

EID: 77958002958     PISSN: 01433636     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNM.0b013e32833ce32c     Document Type: Article

References (25)

1. Carragee EJ. Pyogenic vertebral osteomyelitis. J Bone Joint Surg Am 1997; 79:874-880.
2. Torda AJ, Gottlieb T, Bradbury R. Pyogenic vertebral osteomyelitis: analysis of 20 cases and review. Clin Infect Dis 1995; 20:320-328.
3. Honan M, White GW, Eisenberg GM. Spontaneous infectious discitis in adults. Am J Med 1996; 100:85-89.
4. Carragee EJ, Kim D, Van der Vlugt T, Vittum D. The clinical use of erythrocyte sedimentation rate in pyogenic vertebral osteomyelitis. Spine 1997; 22:2089-2093.
5. Chen HC, Tzaan WC, Lui TN. Spinal epidural abscesses: a retrospective analysis of clinical manifestations, sources of infection, and outcomes. Chang Gung Med J 2004; 27:351-358.
6. Welling MM, Paulusma-Annema A, Balter HS, Pauwels EK, Nibbering PH. Technetium-99m labelled antimicrobial peptides discriminate between bacterial infections and sterile inflammations. Eur J Nucl Med 2000; 27:292-301.
7. Lupetti A, Welling MM, Pauwels EK, Nibbering PH. Radiolabelled antimicrobial peptides for infection detection. Lancet Infect Dis 2003; 3:223-229.
8. Chiesa R, Melissano G, Castellano R, Fernandez Zamora C, Astore D, Samuel A, et al. Avidin and 111In-labelled biotin scan: a new radioisotopic method for localising vascular graft infection. Eur J Vasc Endovasc Surg 1995; 10:405-414.
9. Rusckowski M, Paganelli G, Hnatowich DJ, Magnani P, Virzi F, Fogarasi M, et al. Imaging osteomyelitis with streptavidin and indium-111-labeled biotin. J Nucl Med 1996; 37:1655-1662.
10. Samuel A, Paganelli G, Chiesa R, Sudati F, Calvitto M, Melissano G, et al. Detection of prosthetic vascular graft infection using avidin/indium-111- biotin scintigraphy. J Nucl Med 1996; 37:55-61.
11. Lazzeri E, Manca M, Molea N, Marchetti S, Consoli V, Bodei L, et al. Clinical validation of the avidin/indium-111 biotin approach for imaging infection/inflammation in orthopaedic patients. Eur J Nucl Med 1999; 26:606-614.
12. Lazzeri E, Pauwels EKJ, Erba P, Volterrani D, Manca M, Bodei L, et al. Clinical feasibility of two-step streptavidin/111In-biotin scintigraphy in patients with suspected vertebral osteomyelitis. Eur J Nucl Med 2004; 31:1505-1511.
13. Shoup TM, Fischman AJ, Jaywook S, Babich JW, Strauss HW, Elmaleh DR. Synthesis of fluorine-18-labeled biotin derivatives: biodistribution and infection localization. J Nucl Med 1994; 35:1685-1690.
14. Lazzeri E, Erba P, Perri M, Tascini C, Doria R, Giorgetti J, et al. Scintigraphic imaging of vertebral osteomyelitis with 111In-biotin. Spine (Phila Pa 1976) 2008; 33:E198-E204.
15. Lazzeri E, Erba P, Perri M, Doria R, Tascini C, Mariani G. Clinical impact of SPECT/CT with In-111 biotin on the management of patients with suspected spine infection. Clin Nucl Med 2010; 35:12-17.
16. Wright LD, Cresson EL, Valentick K, Skeggs HR. Microbiological characterization of biocytin. Federation Proc 1950; 9:374.
17. Broquist HP, Snell EE. Biotin and bacterial growth I. Relation to aspartate, oleate, and carbon dioxide. J Biol Chem 1951; 188:431-444.
18. Gretler CA, Mucciolo P, Evans JB, Niven CF. Vitamin nutrition of the staphylococci with special reference to their biotin requirements. J Bacteriol 1955; 70:44-49.
19. Piffeteau A, Gaudry M. Biotin uptake: influx, efflux, and countertransport in Escherichia coli. Biochim Biophys Acta 1985; 816:77-82.
20. Hugo WB, Davidson JR. Effect of cell lipid depletion in Staphylococcus aureus upon its resistance to antimicrobial agents. Microbios 1973; 8:43-51.
21. Waller JR, Lichstein HC. Factors affecting the accumulation of biotin by Lactobacillus arabinosus. J Bacteriol 1961; 81:65-69.
22. Rogers TO, Lichstein HC. Characterization of the biotin transport system in Saccharomyces cerevisiae. J Bacteriol 1969; 100:557-564.
23. Rogers TO, Lichstein HC. Regulation of biotin transport in Saccharomyces cerevisiae. J Bacteriol 1969; 100:565-572.
24. Wright LD, Cresson EL, Skeggs HR. Biocytin in bacterial deamination of aspartic acid. Proc Soc Exp Biol Med 1950; 74:334-335.
25. Prakash OM, Eisenberg MA. Active transport of biotin in Escherichia coli K-12. J Bacteriol 1974; 120:785-791.